Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring

@article{Staner2005NextdayRE,
  title={Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring},
  author={Luc Staner and St{\'e}phane Ertl{\'e} and Peter H. Boeijinga and Gilbert Rinaudo and M. A. Arnal and Alain Muzet and R{\'e}my Luthringer},
  journal={Psychopharmacology},
  year={2005},
  volume={181},
  pages={790-798}
}
RationaleMost studies that investigated the next-day residual effects of hypnotic drugs on daytime driving performances were performed on healthy subjects and after a single drug administration.ObjectivesIn the present study, we further examine whether the results of these studies could be generalised to insomniac patients and after repeated drug administration.MethodSingle and repeated (7 day) doses of zolpidem (10 mg), zopiclone (7.5 mg), lormetazepam (1 mg) or placebo were administered at… Expand
Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study
TLDR
Zopiclone 7.5 mg significantly impaired on-the-road driving performance in both insomnia groups and healthy controls, and the magnitude of impairment was significantly less in the chronic users group as compared with the controls. Expand
Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteon.
TLDR
At the FDA-approved 20 mg dose to treat Non-24, tasimelteon did not impair next-day driving performance compared to placebo in adult healthy volunteers and the lack of clinically meaningful and statistically significant finding was supported by the symmetry analysis, which showed the distribution of within-subject differences between tasimalteon and placebo was symmetric about zero. Expand
Impaired driving performance associated with effect of time duration in patients with primary insomnia.
TLDR
Findings revealed that primary insomnia is associated with a performance decrement during a simulated monotonous driving task and it appears advisable for clinicians to warn patients about their impaired driving performance that could lead to an increased risk of driving accidents. Expand
The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers
TLDR
Ramelteon may affect road-tracking performance, visual attention and/or psychomotor speed measured by Trail-Making Test part A, and body balance in acute dosing, and Physicians should consider risks and benefits when prescribing both drugs. Expand
Sublingual Flumazenil for the Residual Effects of Hypnotics: Zolpidem and Brotizolam
TLDR
Sublingual administration of Flumazenil is safe and effective in reversing the hypnotic effects of Zolpidem and Brotizolam and may offer a comprehensive and safer treatment for insomniac patients. Expand
7 of Hypnotics on Sleep and Quality of Life in Insomnia
Summary This chapter provides an overview of the effects of hypnotics on sleep and quality of life (QOL). In the 1970s it was accepted that a consequence of taking longer acting benzodiazepineExpand
Effects of Hypnotics on Sleep and Quality of Life in Insomnia
TLDR
Limited evidence is provided that newer formulations and different treatment schedules, including intermittent use, can sustain hypnotic efficacy with the Z drugs over longer periods, enhancing QOL and waking function, and without rebound insomnia following withdrawal. Expand
Zolpidem and zopiclone impair similarly monotonous driving performance after a single nighttime intake in aged subjects
TLDR
This is the first study revealing residual effects of Zp on driving performance in ageing drivers which are similar to that of Zc, and patients should be warned at the time of treatment initiation that they should avoid driving. Expand
Impact of Psychotropic Medications on Simulated Driving
TLDR
Computer-simulated driving provides a useful tool to research psychotropicrelated impairment of driving abilities, butLimitations of currently available data include the lack of generalisability, standardisation and small sample sizes. Expand
Good night, sleep tight : performance and EEG measures in primary insomnia patients and during sleep deprivation in health volunteers
TLDR
The research demonstrates specific changes of brain activity during driving and during sleep in this population compared to good sleepers and shows a cumulative effect of sleep deprivation and task duration effects on real driving performance. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
Lormetazepam effects on daytime vigilance, psychomotor performance and simulated driving in young adult healthy volunteers.
TLDR
The data suggest that 3-day use of lormetazepam 1 mg/day neither influences daytime vigilance nor impairs psychomotor task performance and simulated driving. Expand
Residual effects of sleep medication on driving ability.
TLDR
Patients treated with benzodiazepine hypnotics or zopiclone should be cautioned when driving a car, and tolerance develops to the impairing effects of hypnotics, but this is a slow process, and impairment may persist. Expand
Effects of Alprazolam on Driving Ability, Memory Functioning and Psychomotor Performance: A Randomized, Placebo-controlled Study
TLDR
Alprazolam users must be warned not to drive an automobile or operate potentially dangerous machinery after receiving treatment for anxiety and panic disorder. Expand
Residual effects of evening and middle‐of‐the‐night administration of zaleplon 10 and 20 mg on memory and actual driving performance
Zaleplon, a new pyrazolopyrimidine hypnotic, possesses an unusually short elimination half‐life (ca 1 h). This study was conducted to determine whether middle‐of‐the‐night administration of zaleplonExpand
Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol.
TLDR
Zaleplon 10 mg has no residual effects on driving when taken at bedtime, 10 hours before driving, and zopiclone 7.5 mg can cause marked residual impairment, patients should be advised to avoid driving the morning after zopylone administration. Expand
Repeated dose effects of lormetazepam and flurazepam upon driving performance
TLDR
All drugs improved sleep quality and prolonged sleep duration to more or less the same extent. Expand
A comparative study of on‐the‐road and simulated driving performance after nocturnal treatment with lormetazepam 1 mg and oxazepam 50 mg
The main purpose of this study was to compare the sensitivity of a driving simulator test model (TS2) with a standard on‐the‐road driving test, after one night treatment with lormetazepam 1 mg,Expand
Residual Effects of Hypnotics
The risk of ‘hangover’ effects, e.g. residual daytime sleepiness and impairment of psychomotor and cognitive functioning the day after bedtime administration, is one of the main problems associatedExpand
Twenty-four-hour sleep-wake function and personality patterns in chronic insomniacs and healthy controls.
TLDR
A test for unintentional sleep suggested that poor sleep function in insomniacs is related to deficient sleep-controlling mechanisms, rather than psychological trait and state factors. Expand
The leeds sleep evaluation questionnaire in psychopharmacological investigations—a review
TLDR
Dose-related improvements in the self-reported ratings of getting to sleep and perceived quality of sleep were generally associated with reductions in theSelf-reported levels of alertness and behavioural integrity the morning following the nocturnal administration of sedative hypnotic and anti-anxiety agents. Expand
...
1
2
3
4
5
...